HK1209782A1 - Compositions comprising chalcogenides and related methods - Google Patents

Compositions comprising chalcogenides and related methods Download PDF

Info

Publication number
HK1209782A1
HK1209782A1 HK15110369.5A HK15110369A HK1209782A1 HK 1209782 A1 HK1209782 A1 HK 1209782A1 HK 15110369 A HK15110369 A HK 15110369A HK 1209782 A1 HK1209782 A1 HK 1209782A1
Authority
HK
Hong Kong
Prior art keywords
chalcogenides
compositions
related methods
reduced form
methods
Prior art date
Application number
HK15110369.5A
Other languages
English (en)
Chinese (zh)
Inventor
Mark B. Roth
Michael L. MORRISON
Akiko Iwata
Original Assignee
Fred Hutchinson Cancer Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fred Hutchinson Cancer Research Center filed Critical Fred Hutchinson Cancer Research Center
Publication of HK1209782A1 publication Critical patent/HK1209782A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • C01B17/24—Preparation by reduction
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • C01B17/32—Hydrosulfides of sodium or potassium
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B19/00—Selenium; Tellurium; Compounds thereof
    • C01B19/007—Tellurides or selenides of metals
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B19/00—Selenium; Tellurium; Compounds thereof
    • C01B19/04—Binary compounds including binary selenium-tellurium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/08—Tubes; Storage means specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
HK15110369.5A 2012-06-13 2013-06-12 Compositions comprising chalcogenides and related methods HK1209782A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261659311P 2012-06-13 2012-06-13
US201261659311P 2012-06-13
US201361798043P 2013-03-15 2013-03-15
US201361798043P 2013-03-15
PCT/US2013/045395 WO2013188528A1 (en) 2012-06-13 2013-06-12 Compositions comprising chalcogenides and related methods

Publications (1)

Publication Number Publication Date
HK1209782A1 true HK1209782A1 (en) 2016-04-08

Family

ID=49758688

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110369.5A HK1209782A1 (en) 2012-06-13 2013-06-12 Compositions comprising chalcogenides and related methods

Country Status (13)

Country Link
US (1) US20150290240A1 (cg-RX-API-DMAC10.html)
EP (1) EP2861718A4 (cg-RX-API-DMAC10.html)
JP (1) JP2015527975A (cg-RX-API-DMAC10.html)
KR (1) KR20150021509A (cg-RX-API-DMAC10.html)
CN (1) CN104471058A (cg-RX-API-DMAC10.html)
AU (1) AU2013274325A1 (cg-RX-API-DMAC10.html)
BR (1) BR112014030992A2 (cg-RX-API-DMAC10.html)
CA (1) CA2875212A1 (cg-RX-API-DMAC10.html)
HK (1) HK1209782A1 (cg-RX-API-DMAC10.html)
IN (1) IN2014MN02391A (cg-RX-API-DMAC10.html)
MX (1) MX2014014524A (cg-RX-API-DMAC10.html)
RU (1) RU2015100257A (cg-RX-API-DMAC10.html)
WO (1) WO2013188528A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015120458A1 (en) * 2014-02-10 2015-08-13 Fred Hutchinson Cancer Research Center Halogen treatment of heart attack and ischemic injury
CN109650353A (zh) * 2019-01-14 2019-04-19 成都中建材光电材料有限公司 一种高纯二硫化硒的制备方法
US20230256003A1 (en) * 2020-06-25 2023-08-17 Industry-University Cooperation Foundation Hanyang University Erica Campus Pharmaceutical composition for preventing or treating sepsis containing functionalized transition metal dichalcogenide
CN114471430B (zh) * 2022-02-07 2024-01-02 天津大学 一种连续生产碱金属硫化物的装置及其合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499852A (en) * 1975-03-04 1978-02-01 Smith & Nephew Pharma Packaging
US5208336A (en) * 1990-10-19 1993-05-04 Sterling Drug Inc. Selenomerocyanines and processes for preparation and methods of use and compositions thereof
US5616214A (en) * 1995-09-12 1997-04-01 Pulp And Paper Research Institute Of Canada Determination of sodium sulfide and sulfidity in green liquors and smelt solutions
PE20001435A1 (es) * 1998-11-16 2000-12-14 Paques Bio Syst Bv Proceso para la produccion de sulfuro de hidrogeno a partir de azufre en su condicion elemental y uso del mismo en la recuperacion de metales pesados
US6579705B2 (en) * 2001-04-04 2003-06-17 Consortium Fur Elektrochemische Industrie Gmbh Process for preparing non-proteinogenic L-amino acids
KR100906949B1 (ko) * 2002-02-26 2009-07-08 가부시키가이샤 구라레 수지 조성물 및 다층 구조체
MXPA06013250A (es) * 2004-05-14 2007-02-28 Abbott Lab Inhibidores de quinasa como agentes terapeuticos.
US20080226750A1 (en) * 2006-04-20 2008-09-18 Fred Hutchinson Cancer Research Center Methods, Compositions and Articles of Manufacture for Treating Shock and Other Adverse Conditions
KR101538727B1 (ko) * 2006-10-05 2015-07-22 이카리아 인코포레이티드 액체 칼코게나이드 조성물 및 이의 제조방법과 사용방법
JP5083753B2 (ja) * 2007-02-26 2012-11-28 独立行政法人理化学研究所 ４，５−ジメチル−［１，３］ジセレノール−２−セロンの新規製造方法
JP4028588B2 (ja) * 2007-04-27 2007-12-26 政弘 井筒 リグノセルロース系バイオマスの利用方法
EP3246034A1 (en) * 2008-03-06 2017-11-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents

Also Published As

Publication number Publication date
MX2014014524A (es) 2015-02-24
KR20150021509A (ko) 2015-03-02
CA2875212A1 (en) 2013-12-19
US20150290240A1 (en) 2015-10-15
IN2014MN02391A (cg-RX-API-DMAC10.html) 2015-08-21
JP2015527975A (ja) 2015-09-24
WO2013188528A1 (en) 2013-12-19
RU2015100257A (ru) 2016-08-10
CN104471058A (zh) 2015-03-25
EP2861718A4 (en) 2016-03-23
BR112014030992A2 (pt) 2017-06-27
EP2861718A1 (en) 2015-04-22
AU2013274325A1 (en) 2014-12-11

Similar Documents

Publication Publication Date Title
IL252952A0 (en) Diaminocarboxamide and diaminocarbonitrile converted pyrimidines, their compositions and methods of treatment
IL229477A0 (en) Immunoconjugates, compounds containing them, and methods for preparation and use
IL227625A0 (en) Nanoparticle compounds, their formulations, and their use
WO2012042371A3 (en) Pharmaceutical composition
EP2523944A4 (en) COMPOUNDS AND COMPOSITIONS FOR IMPROVING COGNITION, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT
AP2014007657A0 (en) Novel benzopyran compounds, compositions and uses thereof
PL2768936T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2014131739A3 (en) Substituted imidazopyridazines
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
HK1204928A1 (en) Inhibitors of the notch signalling pathway and secretion for use in medicine
PH12016500054A1 (en) Substituted pyrazolo-pyridinamines
MX2015017011A (es) Compuestos nuevos para el tratamiento del cancer.
EP3037093A4 (en) Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating chronic obstructive pulmonary diseases
WO2012017321A3 (en) Treatment for dyslipidemia
EP2794806A4 (en) AZEOTROPÄHNLICHE COMPOSITIONS WITH CIS-1-CHLORO-3,3,3-TRIFLUORPROPEN
WO2012063269A3 (en) Process for preparing iloperidone
MX2014014524A (es) Composiciones que comprenden calcogenuros y metodos relacionados.
EP3061448A4 (en) Composition containing eugenol as active ingredient for preventing or treating atopic dermatitis
EP3037091A4 (en) Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma
WO2012082942A3 (en) Neuropeptide analogs, compositions, and methods for treating pain
WO2012158493A3 (en) Compounds that bind to the erythropoietin receptor
WO2014005942A3 (en) Essential oil of sweet marjoram, composition comprising it, cosmetic treatment method and use
IL235312A0 (en) Taxane compounds, preparations and methods
WO2012119045A3 (en) Compositions and uses thereof to ameliorate pain